Cesca
develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases... Read moreCesca
develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases... Read more
News
Dec 30, 2019
BioPortfolio
Cesca: Cesca Therapeutics Inc KOOL Financial and Strategic SWOT Analysis Review Report Updated 28032019 Prices from USD $106
Nov 06, 2019
BioSpace
Cesca: ThermoGenesis Holdings To Announce Financial Results For The Third Quarter Ended September 30, 2019 And Provide A Corporate Strategic Update
Oct 31, 2019
BioSpace
Cesca: Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus
Oct 24, 2019
centralcharts
Press Release: Cesca : Cesca Therapeutics' CAR-TXpress aims to 'dramatically' reduce manufacturing costs for CAR-T cells
Oct 23, 2019
The Business Journals: Sacramento
Cesca: Cesca to launch immune cell banking service
Oct 22, 2019
Seeking Alpha
Cesca: Cesca forms JV to commercialize cell processing platform; shares up 5%
Oct 02, 2019
BioSpace
Cesca: Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee
Sep 25, 2019
StreetInsider
Press Release: Cesca : ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices
Sep 11, 2019
marketexclusive
Cesca: CESCA THERAPEUTICS INC. (NASDAQ:KOOL) Files An 8-K Regulation FD Disclosure
Sep 09, 2019
BioSpace
Cesca: Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products
